Gufic BioSciences Reports Flat Performance in Q2, Highest DPS in 5 Years
Gufic BioSciences, a smallcap pharmaceutical company, reported a flat performance in the second quarter of fiscal year 2024-2025. The company's dividend per share has increased, but its operating profit to interest ratio is the lowest in five quarters. Investors are advised to hold their position in the company's stock, according to MarketsMojo.
Gufic BioSciences, a smallcap pharmaceutical company, recently announced its financial results for the quarter ended September 2024. The company's stock has been given a 'Hold' call by MarketsMOJO.
According to the financial report, Gufic BioSciences has shown a flat performance in the second quarter of the fiscal year 2024-2025. The company's score has remained the same in the last three months.
However, there are some positive aspects to the company's financials. Gufic BioSciences has recorded the highest dividend per share (DPS) in the last five years, at Rs 0.10 annually. This indicates that the company is distributing higher dividends from its profits.
On the other hand, there are some areas of concern for Gufic BioSciences. The company's operating profit to interest ratio in the last five quarters has been the lowest at 7.46 times. This suggests that the company's ability to manage interest payments is deteriorating. Additionally, the interest cost for the company has been the highest in the last five quarters, at Rs 5.18 crore, and has increased by 12.12% quarter-on-quarter. This could indicate increased borrowings for the company.
Overall, Gufic BioSciences has shown a stable financial performance in the recent quarter, with some positive and negative aspects to consider. Investors are advised to hold their position in the company's stock, as suggested by MarketsMOJO.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
